Andrej Barbic is senior patent counsel in the Litigation Department and a member of the Firm’s Intellectual Property and Life Sciences Patent Groups. Dr. Barbic’s practice focuses on U.S. and foreign patent counseling and portfolio development, post-grant proceedings in the United States Patent Office (USPTO) and patent litigation, particularly pharmaceutical litigation. His clients range from small biotechnology companies to large multinational pharmaceutical companies.
Dr. Barbic regularly counsels clients on patent strategy related to small molecules, pharmaceutical formulations, rational drug design, protein engineering, genome editing, DNA sequencing, diagnostics and other areas of biotechnology in an effort to build robust patent portfolios that can stand up to challenges in the USPTO after grant.
He has successfully defended and challenged numerous patents and successfully argued for his client’s positions at the Patent Trial and Appeal Board (PTAB). He frequently works with colleagues on the engineering side of the practice on a variety of post-grant matters. He serves as the co-chair of Contested Matters Committee of the Boston Patent Law Association, which is responsible for post grant proceedings.
Dr. Barbic has conducted research in DNA and protein structure, interactions of antibiotics with DNA, use of enzymes in organic solvents, manufacture of pharmaceutical formulations, plasma physics and bioinformatics.
Articles in the National Law Review database by Andrej Barbic